SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037483
Filing Date
2020-08-06
Accepted
2020-08-06 13:00:51
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20200630.htm   iXBRL 10-Q 1958528
2 EX-10.1 cbio-ex101_66.htm EX-10.1 96661
3 EX-31.1 cbio-ex311_7.htm EX-31.1 14099
4 EX-31.2 cbio-ex312_67.htm EX-31.2 14076
5 EX-32.1 cbio-ex321_6.htm EX-32.1 9717
6 EX-32.2 cbio-ex322_68.htm EX-32.2 9694
7 GRAPHIC gez10j5fedtm000001.jpg GRAPHIC 32764
  Complete submission text file 0001564590-20-037483.txt   6872381

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cbio-20200630.xsd EX-101.SCH 46966
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20200630_cal.xml EX-101.CAL 35548
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20200630_def.xml EX-101.DEF 126482
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20200630_lab.xml EX-101.LAB 337550
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20200630_pre.xml EX-101.PRE 257084
13 EXTRACTED XBRL INSTANCE DOCUMENT cbio-10q_20200630_htm.xml XML 1261838
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 201080799
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences